| Analysis | Metabolite Name | Measured Value | Units | Group |
|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.1484 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.3729 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.3946 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.4065 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.4716 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.4732 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.4862 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.5057 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.5265 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.5327 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.5346 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.5374 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.5393 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.5571 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.5573 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.5679 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.5863 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.6025 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.6039 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.6055 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.6336 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.6350 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.6446 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.6490 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.6720 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.6756 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.6942 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.7024 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.7046 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.7073 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.7136 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.7191 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.7236 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.7448 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.7451 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.7571 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.7573 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.7697 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.7705 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.7827 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.7903 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.8070 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.8086 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.8222 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.8256 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.8398 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.8418 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.8430 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.8467 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.8482 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.8502 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.8645 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.8813 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.8869 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.8898 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.9001 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.9042 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.9043 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.9317 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.9575 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.9618 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.9640 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.9815 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.9869 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 0.9931 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.0000 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.0097 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.0327 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.0362 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.0408 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.0560 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.0579 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.0888 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.0964 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.0972 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.1101 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.1152 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.1209 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.1518 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.1767 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.1861 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.1992 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.1993 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.2149 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.2432 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.2585 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.2640 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.2759 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.2970 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.3121 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.3159 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.3592 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.3730 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.3899 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.3988 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.4127 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.4274 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.4594 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.4624 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.4638 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.4712 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.4729 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.4779 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.5823 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.6131 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.6168 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.6416 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.6611 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.6730 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.6935 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.7298 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.7528 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.8765 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 1.9339 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 2.0038 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 2.0742 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 2.1308 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 2.1593 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 2.2005 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 2.2442 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 2.3112 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 2.3287 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 2.3344 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 2.3818 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 2.3955 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 2.6085 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 2.6113 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 2.7390 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 2.9817 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 1-methylnicotinamide | 3.1852 | Peak area | Lean |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|